Pharmaceutical trade
Oriola-KD engages in Pharmaceutical retail in Sweden and Russia and Pharmaceutical Wholesale in Finland, Sweden, Russia, Estonia and Latvia as well as Pre-wholesale in Lithuania.
Pharmaceutical Trade Finland’s net sales in 2009 were EUR 504.5 million (EUR 533.4 million) and its operating profit was EUR 18.1 million (EUR 16.6 million).
Pharmaceutical Trade Sweden’s net sales in January-December 2009 were EUR 547.0 million (EUR 535.9 million) and its operating profit was EUR -5.0 million (EUR 6.0 million). Excluding costs related to market change in Sweden, the Pharmaceutical Trade Sweden's operating profit in 2009 was EUR 5.9 million.
Pharmaceutical Trade Russia’s net sales in December 2009 were EUR 480.7 million (pro forma EUR 414.9 million), of which wholesale trade accounted for EUR 382.0 million (EUR 311.4 million) and retail for EUR 98.7 million (EUR 103.5 million). Operating profit was EUR 44.5 million (pro forma EUR 7.4 million). The retail and wholesale companies acquired in Russia have been consolidated into Oriola-KD's accounts as of 1 April 2008.
Pharmaceutical Trade Baltic Countries’ net sales in 2009 were EUR 35.7 million (EUR 37.4 million) and operating profit was EUR 0.9 million (EUR 1.1 million).